<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03895853</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0986</org_study_id>
    <secondary_id>NCI-2019-01392</secondary_id>
    <secondary_id>2018-0986</secondary_id>
    <secondary_id>P30CA016672</secondary_id>
    <nct_id>NCT03895853</nct_id>
  </id_info>
  <brief_title>Early Metabolic Resuscitation for Septic Shock</brief_title>
  <official_title>Early Metabolic Resuscitation: A Potential Solution to Multi-Organ Dysfunction Syndrome in Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase II trial studies how well early metabolic resuscitation therapy works in reducing&#xD;
      multi-organ dysfunction in patients with septic shock. Early metabolic resuscitation is made&#xD;
      of large doses of glucose, protein, and essential metabolic molecules that may help lower the&#xD;
      effects of septic shock on the body. Giving patients early metabolic resuscitation in&#xD;
      combination with standard of care may work better in reducing multi-organ dysfunction&#xD;
      syndrome in patients with septic shock compared to standard of care alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To assess the efficacy of administering early metabolic resuscitation with standard of&#xD;
      care (SC + EMR) in patients diagnosed with septic shock for reducing 28-day mortality versus&#xD;
      using the standard of care alone (SC).&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To assess whether early metabolic resuscitation with standard of care (SC + EMR) is an&#xD;
      effective strategy to reduce intensive care unit (ICU) mortality, hospital mortality, and&#xD;
      90-day mortality of septic shock patients relative to SC.&#xD;
&#xD;
      II. To compare the time to death from any cause between patients administered SC + EMR versus&#xD;
      SC after being diagnosed with septic shock.&#xD;
&#xD;
      III. To assess whether SC + EMR is an effective strategy to reduce complications of septic&#xD;
      shock such as: i) acute kidney injury, ii) dialysis requirements, iii) need for&#xD;
      cardiovascular support or days on vasopressors, iv) need for invasive ventilation, days on&#xD;
      ventilator support, v) duration of ICU stay, and vi) duration of hospital stay versus SC.&#xD;
&#xD;
      IV. To describe the presence of any adverse effects between the two study groups (SC + EMR&#xD;
      group versus [vs] SC group); thus, characterizing their safety.&#xD;
&#xD;
      OUTLINE: Patients are randomized to 1 of 2 groups.&#xD;
&#xD;
      GROUP I: Patients receive standard of care for septic shock.&#xD;
&#xD;
      GROUP II: Patients receive standard of care treatment for septic shock and early metabolic&#xD;
      resuscitation (IV) over continuous infusion for up to 7 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    At the request of the PI&#xD;
  </why_stopped>
  <start_date type="Actual">October 4, 2019</start_date>
  <completion_date type="Actual">May 4, 2020</completion_date>
  <primary_completion_date type="Actual">May 4, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With 28-day Mortality</measure>
    <time_frame>up to 28 days or until death, whichever comes first</time_frame>
    <description>To assess the efficacy of administering Early Metabolic Resuscitation with Standard of Care (SC + EMR) in patients diagnosed with septic shock for reducing 28-day mortality versus using the Standard of Care alone (SC). Twenty-eight day mortality is defined during the time from the day SC+EMR or SC was first administered until a patient dies or is followed through 28 days (whichever comes first).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With 90-Day Mortality</measure>
    <time_frame>up to 90 days or until death, whichever comes first</time_frame>
    <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce ICU mortality, hospital mortality, and 90-day mortality of septic shock patients relative to SC. ICU mortality is defined as mortality at ICU discharge relative to SC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Hospital Mortality</measure>
    <time_frame>up to 90 days or until death, whichever comes first</time_frame>
    <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce hospital mortality of septic shock patients relative to SC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With ICU Mortality</measure>
    <time_frame>up to 90-days or until death, whichever comes first</time_frame>
    <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce ICU mortality of septic shock patients relative to SC. ICU mortality is defined as mortality at ICU discharge relative to SC.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Multiple Organ Failure</condition>
  <condition>Septic Shock</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Group I (standard of care)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive standard of care for septic shock.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (early metabolic resuscitation)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive standard of care treatment for septic shock and early metabolic resuscitation (IV) over continuous infusion for up to 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best Practice</intervention_name>
    <description>Receive standard of care</description>
    <arm_group_label>Group I (standard of care)</arm_group_label>
    <arm_group_label>Group II (early metabolic resuscitation)</arm_group_label>
    <other_name>standard of care</other_name>
    <other_name>standard therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>early metabolic resuscitation</intervention_name>
    <description>Given Intravenous</description>
    <arm_group_label>Group II (early metabolic resuscitation)</arm_group_label>
    <other_name>hyperalimentation</other_name>
    <other_name>EMR</other_name>
    <other_name>glucose</other_name>
    <other_name>protein</other_name>
    <other_name>essential metabolic molecules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to the adult medical intensive care unit (MICU).&#xD;
&#xD;
          -  Diagnosis of septic shock within 12 hours of ICU admission defined as meeting criteria&#xD;
             for sepsis in addition to the following: A) Vasopressor therapy needed to elevate mean&#xD;
             arterial pressure (MAP) &gt;= 65 mmg Hg. B) Lactate &gt; 2 mmol/L (18 mg/dL) after adequate&#xD;
             fluid resuscitation.&#xD;
&#xD;
          -  Sequential Organ Failure Assessment (SOFA) score meeting the following requirements A)&#xD;
             Cardiovascular SOFA &gt;= 2 B) Total SOFA score =&lt; 12.&#xD;
&#xD;
          -  Patients meeting the above and not able to tolerate enteral nutrition above 70% of&#xD;
             their estimated daily caloric need.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Do not resuscitate (DNR).&#xD;
&#xD;
          -  Comfort care and end-of-life patients.&#xD;
&#xD;
          -  Patients with SOFA scores greater than 12.&#xD;
&#xD;
          -  Pregnant women.&#xD;
&#xD;
          -  Jehovah Witnesses that do not accept albumin.&#xD;
&#xD;
          -  Active bleeding (e.g., gastrointestinal bleeding).&#xD;
&#xD;
          -  Acute neurological syndromes (e.g., stroke, hemorrhage, etc.).&#xD;
&#xD;
          -  End-stage renal disease (ESRD).&#xD;
&#xD;
          -  Chronic liver disease&#xD;
&#xD;
               -  Child-Pugh class C&#xD;
&#xD;
               -  Diagnosis of cirrhosis&#xD;
&#xD;
          -  Heart rate less than 50 beats per minute (bpm).&#xD;
&#xD;
          -  Respiratory rate less than 8 respirations per minute (rpm).&#xD;
&#xD;
          -  Temperature less than 95 degrees Fahrenheit (F) or 35 degrees Celsius (C).&#xD;
&#xD;
          -  Tumor lysis syndrome.&#xD;
&#xD;
          -  Sulfite allergy: amino acids administration are contraindicated. It is more common in&#xD;
             steroid dependent asthmatics. (Please note that this is NOT sulfa allergy and is NOT&#xD;
             contraindicated patients with sulfa allergy). Sulfites are present in dried fruits,&#xD;
             beer, wines, sausages, jams, maple syrup, and many other food products.&#xD;
&#xD;
          -  Serum sodium concentration &lt; 130 mEq/L or &gt; 150 mEq/L (Note: Once serum sodium levels&#xD;
             are &gt;= 130 or =&lt; 150 mEq/L within 12 hours after meeting inclusion criteria, the&#xD;
             patient can then be considered for the study. This is only a temporary restriction.&#xD;
&#xD;
          -  Serum creatinine level: Serum creatinine (SCr) &gt; 2.5 mg/dL (Note: Once serum&#xD;
             creatinine levels are =&lt; 2.5 mg/dL within 12 hours after meeting inclusion criteria,&#xD;
             the patient can then be considered for the study. This is only a temporary&#xD;
             restriction).&#xD;
&#xD;
          -  Urine output &lt; 400 cc/24 hours (hrs) plus creatinine &gt; 2.5 mq/dl (Note: Once urine&#xD;
             output levels are &gt;= 400 cc within 12 hours after meeting inclusion criteria, the&#xD;
             patient can then be considered for the study. This is only a temporary restriction).&#xD;
&#xD;
          -  Hyperkalemia K &gt; 5.5 mEq/L (Note: Once potassium levels are =&lt; 5.5 mEq/L within 12&#xD;
             hours after meeting inclusion criteria, the patient can then be considered for the&#xD;
             study. This is only a temporary restriction).&#xD;
&#xD;
          -  Hyperglycemia: Glucose &gt; 250 mg/dL (Note: Once glucose is below 250 mg/dL within 12&#xD;
             hours after meeting inclusion criteria, the patient can then be considered for the&#xD;
             study. This is only a temporary restriction.)&#xD;
&#xD;
          -  Hyperphosphatemia: Serum phosphorous &gt; 5.5 mg/dL.&#xD;
&#xD;
          -  Patient with a history of metabolic abnormality in any one of the following amino&#xD;
             acids: alanine, arginine, cysteine hydrochloride, glycine, histidine, isoleucine,&#xD;
             leucine, lysine acetate, methionine, phenylalanine, phosphoric acid, proline, serine,&#xD;
             threonine, tryptophan, and valine.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph L. Nates, MBA,MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 28, 2019</study_first_submitted>
  <study_first_submitted_qc>March 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2019</study_first_posted>
  <results_first_submitted>February 2, 2021</results_first_submitted>
  <results_first_submitted_qc>March 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 8, 2021</results_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Multiple Organ Failure</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 4, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/53/NCT03895853/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment Period: November 2019- December 2019</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention Group (EMR Solution)</title>
          <description>Standard of care + Early metabolic resuscitation</description>
        </group>
        <group group_id="P2">
          <title>Controlled Group (Standard Care)</title>
          <description>Received standard of care alone</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>No patients were enrolled in the Intervention group.</population>
      <group_list>
        <group group_id="B1">
          <title>Intervention Group (EMR Solution)</title>
          <description>Standard of care + Early metabolic resuscitation</description>
        </group>
        <group group_id="B2">
          <title>Controlled Group (Standard Care)</title>
          <description>Received standard of care alone</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="52" lower_limit="33" upper_limit="71"/>
                    <measurement group_id="B3" value="52" lower_limit="33" upper_limit="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cancer Type</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Gastrointestinal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Breast</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lung</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cancer stage</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Metastatic Stage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Localized/Locally advanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With 28-day Mortality</title>
        <description>To assess the efficacy of administering Early Metabolic Resuscitation with Standard of Care (SC + EMR) in patients diagnosed with septic shock for reducing 28-day mortality versus using the Standard of Care alone (SC). Twenty-eight day mortality is defined during the time from the day SC+EMR or SC was first administered until a patient dies or is followed through 28 days (whichever comes first).</description>
        <time_frame>up to 28 days or until death, whichever comes first</time_frame>
        <population>No participants participated in the Intervention group.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group (EMR Solution)</title>
            <description>Standard of care + Early metabolic resuscitation</description>
          </group>
          <group group_id="O2">
            <title>Controlled Group (Standard Care)</title>
            <description>Received standard of care alone</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With 28-day Mortality</title>
          <description>To assess the efficacy of administering Early Metabolic Resuscitation with Standard of Care (SC + EMR) in patients diagnosed with septic shock for reducing 28-day mortality versus using the Standard of Care alone (SC). Twenty-eight day mortality is defined during the time from the day SC+EMR or SC was first administered until a patient dies or is followed through 28 days (whichever comes first).</description>
          <population>No participants participated in the Intervention group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With 90-Day Mortality</title>
        <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce ICU mortality, hospital mortality, and 90-day mortality of septic shock patients relative to SC. ICU mortality is defined as mortality at ICU discharge relative to SC.</description>
        <time_frame>up to 90 days or until death, whichever comes first</time_frame>
        <population>No participants participated in the Intervention group.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group (EMR Solution)</title>
            <description>Standard of care + Early metabolic resuscitation</description>
          </group>
          <group group_id="O2">
            <title>Controlled Group (Standard Care)</title>
            <description>Received standard of care alone</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With 90-Day Mortality</title>
          <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce ICU mortality, hospital mortality, and 90-day mortality of septic shock patients relative to SC. ICU mortality is defined as mortality at ICU discharge relative to SC.</description>
          <population>No participants participated in the Intervention group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Hospital Mortality</title>
        <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce hospital mortality of septic shock patients relative to SC.</description>
        <time_frame>up to 90 days or until death, whichever comes first</time_frame>
        <population>No participants participated in the Intervention group.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group (EMR Solution)</title>
            <description>Standard of care + Early metabolic resuscitation</description>
          </group>
          <group group_id="O2">
            <title>Controlled Group (Standard Care)</title>
            <description>Received standard of care alone</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Hospital Mortality</title>
          <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce hospital mortality of septic shock patients relative to SC.</description>
          <population>No participants participated in the Intervention group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With ICU Mortality</title>
        <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce ICU mortality of septic shock patients relative to SC. ICU mortality is defined as mortality at ICU discharge relative to SC.</description>
        <time_frame>up to 90-days or until death, whichever comes first</time_frame>
        <population>No participants participated in the Intervention group.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group (EMR Solution)</title>
            <description>Standard of care + Early metabolic resuscitation</description>
          </group>
          <group group_id="O2">
            <title>Controlled Group (Standard Care)</title>
            <description>Received standard of care alone</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With ICU Mortality</title>
          <description>To assess whether Early Metabolic Resuscitation with standard of care (SC + EMR) is an effective strategy to reduce ICU mortality of septic shock patients relative to SC. ICU mortality is defined as mortality at ICU discharge relative to SC.</description>
          <population>No participants participated in the Intervention group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>baseline, up to 1 year</time_frame>
      <desc>No participants were enrolled in the Intervention Group</desc>
      <group_list>
        <group group_id="E1">
          <title>Intervention Group (EMR Solution)</title>
          <description>Standard of care + Early metabolic resuscitation</description>
        </group>
        <group group_id="E2">
          <title>Controlled Group (Standard Care)</title>
          <description>Received standard of care alone</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>CTCAE (4.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_at_risk="0"/>
                <counts group_id="E2" events="7" subjects_affected="2" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joseph L. Nates, Professor, Critical Care&amp; RespiratoryCare</name_or_title>
      <organization>UT MD Anderson Cancer Center</organization>
      <phone>(713) 792-5040</phone>
      <email>jlnates@mdanderson.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

